{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-028206","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.617363+00:00","generated_at":"2026-06-24T03:36:51.003543+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nu Skin Q2 revenue falls 20% to $560.6M; cuts FY guidance, plans restructuring","bullets":["Revenue of $560.6M, down 20% YoY; adjusted EPS of $0.77 (ex. Grow Tech) vs $1.15 prior year.","Paid affiliates fell 16% to 242,133; sales leaders down 24% to 50,085; customers down 6%.","FY 2022 guidance cut: revenue $2.33-2.41B (down 14-11%); adjusted EPS $3.30-$3.60.","Plans H2 restructuring with $35-45M charges; targets ~$100M cost savings in 2023.","U.S. segment posted 9th consecutive quarter of growth; SE Asia/Pac and HK/Taiwan grew on ageLOC Meta."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-028206","json":"https://secwatch.observer/filing/0001140361-22-028206.json","markdown":"https://secwatch.observer/filing/0001140361-22-028206.md","text":"https://secwatch.observer/filing/0001140361-22-028206.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122028206/0001140361-22-028206-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036122028206/brhc10040414_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T03:36:51.003543+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}